Clinical trial
Safety and Efficacy of Telitacicept in Inflammatory Myopathies
NCT07355257 is registered in ClinicalTrials.gov with Zhongming Qiu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Telitacicept in Inflammatory Myopathies
- Lead sponsor
- Zhongming Qiu
- Phase
- Phase 2/3
- Overall status
- Not yet recruiting
- Start date
- February 2, 2026
- Completion date
- March 30, 2027
- Enrollment
- 30 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
inflammatory myopathy